We are proud to announce that the Austrian Agency for Health and Food Safety (AGES) has issued our new GLP certificate. Following an 3-day inspection in May 2024, we received positive feedback from the authority, confirming again that we fulfill the high standards of Good Laboratory Practice (GLP). This certificate, which is renewed every three years, underlines our commitment to quality and reliability in research under regulated conditions, ensuring the integrity and accuracy of the data and our excellence in the field of GLP/GCLP.
The much-anticipated publication “ Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A” has been officially published. This groundbreaking work brings new insights on immunogenicity with data from 6 clinical studies from a cohort of 360 patients with severe Hemophilia A.
We are excited to announce our participation in the 18th WRIB (Workshops on Recent Issues in Bioanalysis), taking place in San Antonio, Texas from May 6th to 10th, 2024.
We are delighted to present the latest addition to our laboratory: the BD FACSLyric™ Flow Cytometry System. This cutting-edge system represents a significant enhancement to our existing flow cytometry platform, which already includes the BD FACS Aria III and the Apogee A50micro.
